Thyas has signed two agreements with the Kyoto University iPS Cell Research Foundation (Sakyo-ku, Kyoto, Representative Director Dr. Shinya Yamanaka).
1. Basic agreement on the outsourcing of the clinical production of autologous iPS cell-derived cytotoxic T cell therapy.
2. Joint research agreement on “my iPS® Project” for the production of autologous iPS cell-derived T cells.

Click here for more details.